Monday June 1, 2020

HPRA to raise fees to drug companies by 8%

Susan Mitchell

Deputy Editor and Health Editor

6th January, 2019

The medicines regulator is proposing to increase its fees to veterinary and pharma companies by 8 per cent.

In submissions to the Health Products Regulatory Authority (HPRA), representative groups warned that their members already faced increased costs due to Brexit and the implementation of the Falsified Medicines Directive.

In a statement, the Irish Pharmaceutical Healthcare Association (IPHA) said: “We consider the fees increase part of the overall Brexit cost which is being passed on to the...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The biggest care home groups are increasing controlled by global funds, while family-owned groups are taking on investors or getting out of the business altogether

Róisín Burke | 1 day ago

In matters of health policy, questions should be answered with honesty and clarity

John Crown | 1 day ago

Elderly now required to isolate for 14 days inside care homes once discharged from hospital

Susan Mitchell | 1 day ago